OSE Immunotherapeutics : and Boehringer Ingelheim expand collaboration to develop first in class treatments for cancer and cardio renal metabolic diseases

OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases


Nantes,...

Related Keywords

Ingelheim ,Rheinland Pfalz ,Germany ,France ,French ,Nicolas Poirier ,Kate Barrette ,Florence Portejoie ,Cliver Wood ,Reinhard Malin ,Melzer Cohen ,Linkedin ,Boehringer Ingelheim ,International Review Of Cell ,Veloxis Pharmaceuticals Inc ,Corporate Affairs ,Nantes University Hospital ,Animal Health ,Corporate Senior Vice President ,Global Head ,Discovery Research ,Molecular Biology ,Human Pharma ,Cell Lung Cancer ,Ulcerative Colitis ,Veloxis Pharmaceuticals ,Unit Comms ,Universal Registration Document ,